Background Cardiovascular complications, including myocardial infarction, ischemic stroke,
and pulmonary embolism, represent an important source of adverse outcomes in …

Background Coronavirus disease 2019 (COVID-19) increases thrombosis in hospitalized
patients prompting adoption of different thromboprophylaxis strategies. Safety and efficacy of …

Background We aimed to identify the prevalence and predictors of venous
thromboembolism (VTE) or mortality in hospitalized coronavirus disease 2019 (COVID-19) …

Background Coagulopathy is a common abnormality in patients with COVID‐19. However,
the exact incidence of venous thromboembolic event is unknown in anticoagulated, severe …

Severe coronavirus disease 2019 (COVID-19) is associated with increased risk of venous
thromboembolism events (VTE). This study performed a systematic review in …

AIMS OF THE STUDY Many centres have noticed a high number of venous
thromboembolism (VTE) events among critically ill inpatients with COVID-19 pneumonia …

Background The incidence of venous thromboembolic events (VTE) in patients with COVID-
19 is generally high but varies markedly. However, the relationship between anticoagulation …

A prothrombotic state is reported with severe COVID-19 infection, which can manifest in
venous and arterial thrombotic events. Coagulopathy is reflective of more severe disease …

Background Few data are available on the rate and characteristics of thromboembolic
complications in hospitalized patients with COVID-19. Methods We studied consecutive …

Background Thrombosis and pulmonary embolism appear to be major causes of mortality in
hospitalized coronavirus disease 2019 (COVID-19) patients. However, few studies have …